Cargando…

Multivariate Analysis of Immune Reconstitution and Relapse Risk Scoring in Children Receiving Allogeneic Stem Cell Transplantation for Acute Leukemias

A timely and effective immune reconstitution after hematopoietic stem cell transplantation (HSCT) is of crucial importance to enhance graft-versus-leukemia reaction in hematological malignancies. Several factors can influence the yield of this process, and new mathematical models are needed to descr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spadea, Manuela, Saglio, Francesco, Tripodi, Serena I., Menconi, Mariacristina, Zecca, Marco, Fagioli, Franca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Bone Marrow and Stem Cell Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500617/ https://www.ncbi.nlm.nih.gov/pubmed/34646937 http://dx.doi.org/10.1097/TXD.0000000000001226

Ejemplares similares

ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

Isolation of a Highly Purified HSC-enriched CD34(+)CD90(+)CD45RA(−) Cell Subset for Allogeneic Transplantation in the Nonhuman Primate Large-animal Model
por: Radtke, Stefan, et al.
Publicado: (2020)

Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin
por: Takamatsu, Hiroyuki, et al.
Publicado: (2021)

Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
por: Malagola, Michele, et al.
Publicado: (2023)

Early expression of CD94 and loss of CD96 on CD8+ T cells after allogeneic stem cell tranplantation is predictive of subsequent relapse and survival
por: Verma, Kriti, et al.
Publicado: (2022)

Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients
por: Gama, Bianca E., et al.
Publicado: (2017)

CD94 Ex Vivo Cultures in a Bone Marrow Transplantation Setting
por: Abrams, Kraig, et al.
Publicado: (2020)

Persistent Facial and Chest Papular and Pustular Eruption in a Stem Cell Transplant Patient
por: Keiser, Monika F., et al.
Publicado: (2021)

Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experience
por: Socie, Gerard, et al.
Publicado: (2023)

Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up
por: Kim, Kyoung Ha, et al.
Publicado: (2023)

A phase II, prospective, randomized, open-label study of defibrotide added to standard-of-care prophylaxis for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation
por: Hudspeth, Michelle, et al.
Publicado: (2022)

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

Transcriptome analysis in acute gastrointestinal graft-versus host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel disease
por: Khandelwal, Pooja, et al.
Publicado: (2023)

Gonadal function in pediatric Fanconi anemia patients treated with hematopoietic stem cell transplant
por: Koo, Jane, et al.
Publicado: (2023)

The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia
por: Kim, Dennis D. H., et al.
Publicado: (2022)

Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage‐specific chimerism analysis
por: Lindahl, Hannes, et al.
Publicado: (2022)

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
por: Maurer, Katie, et al.
Publicado: (2021)

Treatment of allosensitized patients receiving allogeneic transplantation
por: Ciurea, Stefan O., et al.
Publicado: (2021)

Sars-Cov-2 Infection Associated with Aplastic Anemia and Pure Red Cell Aplasia
por: Lee, Nicholas C.J., et al.
Publicado: (2021)

Sars-Cov-2 Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria: An Italian Multicenter Survey
por: Giannotta, Juri Alessandro, et al.
Publicado: (2021)

Acquired Aplastic Anemia in Immunocompetent Pediatric Patients with Asymptomatic COVID-19 Infection: A Case Series
por: Fritch, Jordan E., et al.
Publicado: (2021)

Transforming growth factor-β signaling modifies the hematopoietic acute inflammatory response to drive bone marrow failure
por: Javier, Jose, et al.
Publicado: (2021)

Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children
por: Gilad, Oded, et al.
Publicado: (2022)

Genotype-phenotype and outcome associations in patients with Fanconi anemia: the National Cancer Institute cohort
por: Altintas, Burak, et al.
Publicado: (2022)

Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia
por: Dong, Peiyuan, et al.
Publicado: (2022)

Somatic genetic alterations predict hematological progression in GATA2 deficiency
por: Largeaud, Laetitia, et al.
Publicado: (2023)

Effects of nandrolone decanoate on telomere length and clinical outcome in patients with telomeropathies: a prospective trial
por: Clé, Diego V., et al.
Publicado: (2022)

Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia
por: Lasaga, Miren, et al.
Publicado: (2023)

Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy
por: Nakamura, Ryotaro, et al.
Publicado: (2023)

Type 1 interferon to prevent leukemia relapse after allogeneic transplantation
por: Magenau, John M., et al.
Publicado: (2021)

Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation
por: Godfrey, James, et al.
Publicado: (2022)

Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning
por: Schwaiger, Elisabeth, et al.
Publicado: (2012)

Global longitudinal strain is superior to ejection fraction for long‐term follow‐up after allogeneic hematopoietic stem cell transplantation
por: Watanabe, Marika, et al.
Publicado: (2022)

Stem cell transplantation
por: Schaap, Nicolaas
Publicado: (2019)

CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia
por: Akahoshi, Yu, et al.
Publicado: (2023)

Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers
por: Circosta, Paola, et al.
Publicado: (2022)

Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning
por: Iwasaki, Makoto, et al.
Publicado: (2022)

Assessment of monocytic‐myeloid‐derived suppressive cells (M‐MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patients
por: Peterlin, Pierre, et al.
Publicado: (2023)

Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children
por: Masetti, Riccardo, et al.
Publicado: (2023)

An Unusual Presentation of Nocardiosis in an Allogeneic Transplant Recipient
por: Ibrahim, Uroosa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7o77lchcr038r67ivqhb067bgk